Masimo ROE 2007-2020 | MASI

Current and historical return on equity (ROE) values for Masimo (MASI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Masimo ROE for the three months ending March 31, 2020 was 17.05%.
Masimo ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $0.21B $1.25B 18.47%
2019-12-31 $0.20B $1.17B 18.14%
2019-09-30 $0.19B $1.11B 18.44%
2019-06-30 $0.20B $1.04B 20.17%
2019-03-31 $0.20B $1.01B 21.23%
2018-12-31 $0.19B $0.97B 22.34%
2018-09-30 $0.14B $0.91B 17.22%
2018-06-30 $0.12B $0.83B 15.56%
2018-03-31 $0.12B $0.77B 16.32%
2017-12-31 $0.13B $0.72B 17.96%
2017-09-30 $0.36B $0.72B 54.81%
2017-06-30 $0.35B $0.71B 62.79%
2017-03-31 $0.34B $0.63B 73.77%
2016-12-31 $0.31B $0.56B 85.71%
2016-09-30 $0.11B $0.33B 37.54%
2016-06-30 $0.10B $0.30B 36.50%
2016-03-31 $0.09B $0.27B 32.85%
2015-12-31 $0.08B $0.28B 28.79%
2015-09-30 $0.08B $0.27B 27.00%
2015-06-30 $0.08B $0.28B 25.31%
2015-03-31 $0.07B $0.33B 22.98%
2014-12-31 $0.07B $0.31B 23.10%
2014-09-30 $0.06B $0.28B 19.03%
2014-06-30 $0.06B $0.32B 18.90%
2014-03-31 $0.07B $0.35B 20.22%
2013-12-31 $0.06B $0.33B 19.11%
2013-09-30 $0.06B $0.31B 21.99%
2013-06-30 $0.06B $0.29B 21.31%
2013-03-31 $0.06B $0.28B 21.61%
2012-12-31 $0.06B $0.28B 21.67%
2012-09-30 $0.06B $0.31B 21.25%
2012-06-30 $0.06B $0.30B 21.91%
2012-03-31 $0.06B $0.28B 21.87%
2011-12-31 $0.06B $0.28B 23.04%
2011-09-30 $0.07B $0.30B 24.88%
2011-06-30 $0.07B $0.28B 26.51%
2011-03-31 $0.06B $0.26B 26.69%
2010-12-31 $0.07B $0.23B 31.98%
2010-09-30 $0.07B $0.25B 29.19%
2010-06-30 $0.07B $0.23B 27.28%
2010-03-31 $0.07B $0.21B 26.17%
2009-12-31 $0.05B $0.29B 20.17%
2009-09-30 $0.04B $0.27B 15.51%
2009-06-30 $0.04B $0.25B 16.47%
2009-03-31 $0.04B $0.24B 16.78%
2008-12-31 $0.03B $0.22B 16.20%
2008-09-30 $0.04B $0.21B 24.41%
2008-06-30 $0.04B $0.19B 23.60%
2008-03-31 $0.03B $0.17B 22.56%
2007-12-31 $0.02B $0.15B 25.27%
2007-09-30 $0.02B $0.14B 28.04%
2007-06-30 $0.01B $0.08B 62.34%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.540B $0.938B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $144.509B 29.34
Intuitive Surgical (ISRG) United States $67.694B 50.00
Edwards Lifesciences (EW) United States $42.875B 36.04
DexCom (DXCM) United States $37.617B 175.58
ALCON INC (ALC) Switzerland $28.696B 32.12
IDEXX Laboratories (IDXX) United States $28.432B 66.95
Fresenius Medical Care AG KGaA (FMS) Germany $26.420B 18.00
Olympus (OCPNY) Japan $25.621B 52.11
Teleflex (TFX) United States $17.092B 31.66
Sysmex ADR (SSMXY) Japan $15.528B 43.76
Hologic (HOLX) United States $14.940B 23.52
SONOVA HOLDING (SONVY) Switzerland $13.290B 0.00
STERIS (STE) Ireland $13.083B 27.31
ABIOMED (ABMD) United States $11.884B 63.73
Varian Medical Systems (VAR) United States $11.115B 26.96
SARTORIUS AG (SARTF) Germany $9.169B 78.82
Penumbra (PEN) United States $6.592B 253.99
Tandem Diabetes Care (TNDM) United States $5.925B 0.00
Globus Medical (GMED) United States $4.796B 30.35
Integra LifeSciences Holdings (IART) United States $4.134B 18.96
Nevro (NVRO) United States $4.004B 0.00
Wright Medical Group (WMGI) Netherlands $3.828B 594.00
Elekta AB (EKTAY) Sweden $3.572B 27.50
Nihon Kohden (NHNKY) Japan $2.820B 0.00
LivaNova (LIVN) United Kingdom $2.478B 18.68
Integer Holdings (ITGR) United States $2.373B 14.66
OPKO Health (OPK) United States $2.371B 0.00
Cantel Medical (CMD) United States $1.877B 21.72
Glaukos (GKOS) United States $1.709B 0.00
ShockWave Medical (SWAV) United States $1.512B 0.00
Luminex (LMNX) United States $1.504B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.449B 28.09
Veracyte (VCYT) United States $1.387B 0.00
Silk Road Medical (SILK) United States $1.334B 0.00
Mesa Laboratories (MLAB) United States $0.954B 50.45
GenMark Diagnostics (GNMK) United States $0.924B 0.00
Accelerate Diagnostics (AXDX) United States $0.877B 0.00
Inogen (INGN) United States $0.800B 47.72
Tactile Systems Technology (TCMD) United States $0.786B 99.68
OrthoPediatrics (KIDS) United States $0.786B 0.00
Natus Medical (NTUS) United States $0.742B 18.29
CryoLife (CRY) United States $0.740B 103.26
Quotient (QTNT) Switzerland $0.625B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.618B 24.95
Pacific Biosciences Of California (PACB) United States $0.577B 0.00
Si-Bone (SIBN) United States $0.458B 0.00
AxoGen (AXGN) United States $0.457B 0.00
Intersect ENT (XENT) United States $0.447B 0.00
Vermillion (AWH) United States $0.394B 0.00
Repro-Med Systems (KRMD) United States $0.394B 302.33
AngioDynamics (ANGO) United States $0.389B 25.83
TransMedics (TMDX) United States $0.372B 0.00
ViewRay (VRAY) United States $0.345B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.339B 0.00
Alphatec Holdings (ATEC) United States $0.318B 0.00
Fluidigm (FLDM) United States $0.317B 0.00
Semler Scientific (SMLR) United States $0.296B 32.75
IRadimed (IRMD) United States $0.289B 31.12
SeaSpine Holdings (SPNE) United States $0.284B 0.00
RTI Surgical (RTIX) United States $0.219B 0.00
Sientra (SIEN) United States $0.205B 0.00
Accuray (ARAY) United States $0.196B 0.00
T2 Biosystems (TTOO) United States $0.167B 0.00
Restoration Robotics (VERO) Canada $0.113B 0.00
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
EDAP TMS S.A (EDAP) France $0.074B 36.57
Bioanalytical Systems (BASI) United States $0.057B 0.00
MRI Interventions (CLPT) United States $0.056B 0.00
Ekso Bionics Holdings (EKSO) United States $0.056B 0.00
ConforMIS (CFMS) United States $0.056B 0.00
Sensus Healthcare (SRTS) United States $0.050B 0.00
Allied Healthcare Products (AHPI) United States $0.046B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.043B 0.00
Apollo Endosurgery (APEN) United States $0.035B 0.00
Neuronetics (STIM) United States $0.034B 0.00
Delcath Systems (DCTH) United States $0.027B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
DarioHealth (DRIO) Israel $0.024B 0.00
Second Sight Medical Products (EYES) United States $0.022B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.020B 0.00
Sunshine Heart Inc (CHFS) United States $0.019B 0.00
Helius Medical Technologies (HSDT) United States $0.018B 0.00
ReWalk Robotics (RWLK) Israel $0.018B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
Dynatronics (DYNT) United States $0.013B 0.00
Lianluo Smart (LLIT) China $0.011B 0.00
Avinger (AVGR) United States $0.010B 0.00
Nanovibronix (NAOV) United States $0.009B 0.00
Viveve Medical (VIVE) United States $0.009B 0.00
Ra Medical Systems (RMED) United States $0.007B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00